病例报告:在针对性治疗后复发的背景下,亚临床外性B-ALL

Claire Johns1, Courtney Erickson1, Ashley Jacobs1

  • 1Division of Pediatric Hematology/Oncology/Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford Medicine, Stanford, San Francisco, CA, United States.

Frontiers in immunology
|October 10, 2024
PubMed
概括

对B细胞急性淋巴细胞白血病 (B-ALL) 的标准检测可能会错过显著的外骨髓性疾病. 在CAR-T细胞治疗之前,PET-MRI在两名患者身上发现了大量的亚临床疾病,改变了治疗方法并强调了需要先进的成像.